MedPath

Sedation of Mechanically Ventilated Critically Ill Patients: Midazolam Versus Dexmedetomidine

Phase 4
Conditions
Mechanically Ventilated Patients
Sedation
Dexmedetomidine
Midazolam
Interventions
Registration Number
NCT01256866
Lead Sponsor
Hospital Sao Domingos
Brief Summary

The aim of this prospective randomized study is to compare the safety and efficacy of two strategies for sedation of critically ill patients submitted to mechanical ventilation: continuous intravenous infusion of dexmedetomidine versus intravenous bolus of midazolam. The two groups will be compared as to the incidence of of delirium, evaluated with the Confusion Assessment Method for ICU (CAM-ICU) and the percentage of time within the target sedation using the Richmond Agitation-Sedation Scale (RAAS).Eligible patients will be 18 years or older intubated and mechanically ventilated for less than 48 hours prior to start of study drug and anticipated ventilation duration of at least 48 hours. Calculated sample size is 146 patients (73 patients in each group)

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
146
Inclusion Criteria
  • Adult mechanically ventilated, critically ill patients
Exclusion Criteria
  • pregnancy or lactation, severe liver disease, hearth rate less than 50, hypotension despite volemic repletion and vasoactive drug

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Midazolam, sedation,Midazolam-
DEXMEDETOMIDINE, SEDATIONDexmedetomidine-
Primary Outcome Measures
NameTimeMethod
Incidence of delirium
Secondary Outcome Measures
NameTimeMethod
PERCENTAGE OF TIME WITHIN THE TARGET SEDATION

Trial Locations

Locations (1)

Hospital Sao Domingos

🇧🇷

Sao Luis, Maranhao, Brazil

© Copyright 2025. All Rights Reserved by MedPath